CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net loss	$ (3,116)	$ (57,342)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	39,432	38,764
Interest expense related to amortization of debt issue costs and debt discount	4,999	12,687
Stock-based compensation	1,267	1,379
Deferred income taxes	223	82
Net gain on disposition of property, plant and equipment	(726)	(635)
Gain on sale of discontinued operations, net of income taxes	(2,158)	(267)
Gain on convertible debt repayments	(35)	(2,350)
Asset impairments and non-cash restructuring costs	0	13,602
Net loss of unconsolidated joint ventures	0	6,069
Decrease (increase) in trade receivables	1,066	(1,190)
Decrease (increase) in inventories	(2,931)	2,983
Decrease in accounts payable and accrued liabilities	(25,748)	(5,658)
Other changes in operating assets and liabilities, net	(4,403)	1,850
Net cash provided by operating activities	7,870	9,974
Cash flows from investing activities:
Payments for acquisitions	(43,250)	(900)
Purchase of property, plant and equipment	(21,546)	(18,305)
Proceeds from disposition of property, plant and equipment	855	1,336
Proceeds from sale of discontinued operations	4,813	2,000
Proceeds from sale of interests in joint ventures	0	18,522
Net change in other assets	(1,124)	(974)
Net cash provided by (used in) investing activities	(60,252)	1,679
Cash flows from financing activities:
Net proceeds from issuance of common stock	77,957	0
Payments on long-term debt	(39,476)	(32,931)
Debt issue costs	0	(1,040)
Employee stock purchases	609	484
Net cash provided by (used in) financing activities	39,090	(33,487)
Net decrease in cash and cash equivalents	(13,292)	(21,834)
Cash and cash equivalents, beginning of period	53,782	50,810
Cash and cash equivalents, end of period	$ 40,490	$ 28,976